Showing 1 - 3 results of 3 for search 'Xiao-Dong Mo', query time: 0.02s
Refine Results
-
1
Immunosuppressant indulges EBV reactivation and related lymphoproliferative disease by inhibiting Vδ2+ T cells activities after hematopoietic transplantation for blood malignancies... by Ning Wu, Jiangying Liu, Haitao Gao, Lan-Ping Xu, Xiao-Dong Mo, Ruoyang Liu, Shuang Liang, Ming Wang, Zhidong Wang, Ying-Jun Chang, Xiao-Hui Zhang, Xiao-Jun Huang
Published 2020-05-01
Article -
2
Treatment of minimal residual disease in myeloid malignancies after allo-HSCT with venetoclax-based regimens in patients ineligible for or failed in the immunotherapy by Wen-Jing Yu, Jun Kong, Feng-Mei Zheng, Xiao-Dong Mo, Xiao-Hui Zhang, Lan-Ping Xu, Yuan-Yuan Zhang, Yu-Qian Sun, Jian Jin, Xiao-Jun Huang, Yu Wang
Published 2024-12-01
Article -
3
Letermovir prophylaxis for cytomegalovirus is associated with risk of post-transplant lymphoproliferative disorders after haploidentical stem cell transplantation by Xu-Ying Pei, Qiang Huang, Ling-Jie Luo, Hai-Lu Sun, Jing Liu, Yu-Qian Sun, Xiao-Dong Mo, Meng Lv, Dai-Hong Liu, Hong-Yan Ma, Yan-Wei Wu, Lan-Ping Xu, Yu Wang, Xiao-Hui Zhang, Liang Chen, Xiao-Jun Huang
Published 2024-11-01
Article